Ethema Health Corporation (GRST) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ethema Health Corporation (GRST) trades at $0.0001. Ethema Health Corporation operates within the healthcare sector, specializing in addiction treatment services through its Rental Operations and In-Patient Services segments. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for GRST: GRST does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GRST against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GRST: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Ethema Health Corporation (GRST) Healthcare & Pipeline Overview
Ethema Health Corporation is a healthcare entity focused on providing addiction treatment services through its Rental Operations and In-Patient Services, including the Addiction Recovery Institute of America in Florida. The company aims to address the growing demand for substance abuse solutions, operating within the specialized medical care facilities industry.
What Is the Investment Thesis for GRST?
Ethema Health Corporation operates in the growing addiction treatment sector, a market driven by increasing demand for specialized healthcare services. The company's core assets, including the Addiction Recovery Institute of America, position it to capitalize on this trend through its In-Patient Services and Rental Operations. With a notable gross margin of 91.4%, the company demonstrates efficiency in its service delivery. However, the investment thesis is significantly tempered by substantial risks, including a negative profit margin of -9.3% and a very low market capitalization of $0.00B (or $772,628). The company's listing on the OTC Other tier, coupled with a share price of $0.00, indicates high financial and liquidity risks. Future value drivers hinge on the company's ability to secure sustainable funding, achieve consistent revenue generation, and successfully scale its 'innovative solutions' in addiction treatment. The beta of 0.68 suggests lower volatility relative to the broader market, but this must be weighed against the inherent risks of a micro-cap OTC entity.
Based on FMP financials and quantitative analysis
GRST Key Highlights
The company maintains a strong gross margin of 91.4%, indicating efficient cost management relative to revenue from its services.
- Ethema Health Corporation reported a profit margin of -9.3%, reflecting ongoing challenges in achieving overall profitability.
- With a market capitalization of $0.00B (or $772,628), the company is classified as a micro-cap entity, indicating a small market valuation.
- The stock exhibits a beta of 0.68, suggesting it has historically been less volatile than the overall market.
- Ethema Health Corporation does not currently pay a dividend, consistent with many growth-focused or developing companies.
Who Are GRST's Competitors?
GRST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| JYNT The Joint Corp. | $8.25 | +0.24% | $118M | 75 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GRST's Key Strengths?
High gross margin of 91.4% indicates efficient service delivery cost management.
- Operates in a high-demand sector with increasing need for addiction treatment services.
- Manages a dedicated facility, the Addiction Recovery Institute of America, for in-patient care.
- Focus on developing and marketing 'innovative solutions' within its niche.
What Are GRST's Weaknesses?
Negative profit margin of -9.3% indicates challenges in achieving overall profitability.
- Very low market capitalization ($0.00B or $772,628) and share price ($0.0001) signal significant financial fragility.
- Listing on the OTC Other tier implies limited liquidity and heightened investment risk.
- Ongoing challenges in securing funding and achieving sustainable revenue generation.
What Could Drive GRST Stock Higher?
GRST catalyst: Increasing demand for addiction treatment services provides a persistent market opportunity for the company's specialized offerings.
- Successful securing of additional funding could alleviate liquidity concerns and support operational expansion and innovation initiatives.
- Achievement of sustainable revenue generation and a return to profitability would significantly improve the company's financial outlook and market perception.
- Development and successful market introduction of new 'innovative solutions' in substance abuse treatment could enhance service differentiation and patient attraction.
What Are the Key Risks for GRST?
Financial-distress signal — its Altman Z-Score of -2.21 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant financial and liquidity risks stemming from the company's very low share price and small market capitalization, impacting trading and investor confidence.
- Persistent negative profit margin of -9.3% indicates challenges in achieving and maintaining overall profitability from operations.
- Difficulties in securing adequate funding to support current operations, expansion plans, and the development of innovative solutions.
- Challenges in achieving sustainable revenue generation, which is critical for long-term viability and growth in the competitive healthcare sector.
- Regulatory changes or shifts in healthcare policy related to addiction treatment and reimbursement could adversely affect the company's business model and financial performance.
What Are the Growth Opportunities for GRST?
- **Leveraging Increasing Demand for Addiction Treatment:** The global demand for addiction treatment services continues to rise, driven by increasing awareness, changing societal perceptions, and the ongoing opioid crisis. Ethema Health Corporation, through its Addiction Recovery Institute of America, is directly positioned to benefit from this expanding market. By enhancing its capacity, optimizing patient intake processes, and potentially expanding its geographical reach beyond West Palm Beach, the company could capture a larger share of this growing market. The market for substance abuse treatment is estimated to be a multi-billion dollar industry, with consistent growth projected over the next five to ten years, providing a significant tailwind for specialized providers.
- **Expansion of Innovative Solutions in Treatment:** The company's stated focus on developing and marketing 'innovative solutions' within substance abuse treatment presents a significant growth avenue. This could involve integrating new therapeutic modalities, leveraging technology for improved patient outcomes, or developing specialized programs for specific demographics or types of addiction. Differentiating its services through innovation could enhance its reputation, attract more patients, and potentially command higher service fees. Successful implementation of such solutions could lead to increased patient volumes and improved treatment efficacy, driving revenue growth within a 2-5 year timeline.
- **Optimization and Expansion of Rental Operations:** Ethema Health Corporation's Rental Operations segment offers a distinct revenue stream that can be optimized for growth. This could involve expanding the portfolio of properties available for rent, improving occupancy rates, or diversifying the types of rental services offered within the healthcare or related sectors. Efficient management and strategic expansion of this segment could provide a stable, recurring revenue base that supports the more capital-intensive in-patient services. Maximizing the profitability and scale of rental operations could contribute to overall financial stability and growth within the next 1-3 years.
- **Enhancing In-Patient Services Capacity and Reach:** The In-Patient Services segment, primarily through the Addiction Recovery Institute of America, is central to the company's mission. Growth can be achieved by increasing the number of beds, expanding specialized treatment programs, or improving the patient experience to enhance referral rates and reputation. Investing in facility upgrades, staff training, and evidence-based treatment protocols can strengthen its market position. Expanding the capacity of its in-patient services to serve a broader patient base within Florida or potentially neighboring regions could significantly boost revenue and market share over a 3-5 year horizon.
- **Strategic Partnerships and Acquisitions:** Given the fragmented nature of the addiction treatment market, Ethema Health Corporation could pursue strategic partnerships or targeted acquisitions to expand its service offerings, geographic footprint, or patient base. Collaborating with other healthcare providers, insurance companies, or research institutions could open new referral channels and enhance service integration. Acquiring smaller, complementary treatment centers could provide immediate scale and market penetration. Such strategic moves, if executed effectively, could accelerate growth and consolidate market position within the next 2-4 years, leveraging synergies and expanding operational capabilities.
What Threats Does GRST Face?
- Intense competition from other addiction treatment providers and larger healthcare systems.
- Regulatory changes in the healthcare and addiction treatment sectors could impact operations and profitability.
- Difficulty in securing adequate funding to support operations and growth initiatives.
- Negative market perception and limited investor interest due to its OTC listing and financial profile.
What Are GRST's Competitive Advantages?
- Specialized focus on addiction treatment services within a dedicated facility, the Addiction Recovery Institute of America.
- Existing infrastructure and operational experience in managing in-patient care facilities.
- Potential for 'innovative solutions' in substance abuse treatment, differentiating its service offerings.
- Established presence in West Palm Beach, Florida, serving a specific regional demand.
What Does GRST Do?
Ethema Health Corporation, headquartered in West Palm Beach, Florida, is a dedicated provider of addiction treatment services, operating across various divisions. The company's business model is structured around two primary segments: Rental Operations and In-Patient Services. A key operational asset is the Addiction Recovery Institute of America, a facility also located in West Palm Beach, Florida, which plays a central role in delivering its specialized care. The company's journey began under the name GreeneStone Healthcare Corporation before it underwent a strategic rebranding in April 2017, officially adopting its current identity as Ethema Health Corporation. This transformation solidified its focus on the critical and expanding field of substance abuse treatment. With 65 employees, Ethema Health Corporation positions itself as a specialized player in the healthcare sector, aiming to address the complex challenges associated with addiction. The company's operational footprint is currently concentrated in Florida, leveraging its facility to offer comprehensive in-patient care. Its strategic emphasis on developing and marketing products and services related to substance abuse treatment underscores its commitment to innovation within this niche. While operating in a high-demand sector, the company navigates the competitive landscape of medical care facilities by focusing on its specialized offerings and operational efficiency within its defined segments.
What Products and Services Does GRST Offer?
- Operates within the healthcare sector, specifically focusing on addiction treatment services.
- Manages the Addiction Recovery Institute of America, a facility located in West Palm Beach, Florida.
- Provides in-patient services for individuals seeking substance abuse treatment.
- Engages in Rental Operations, which constitutes a separate business segment.
- Develops and markets products and services related to substance abuse treatment.
- Aims to offer innovative solutions within the niche of addiction recovery.
- Serves individuals struggling with various forms of addiction, providing structured care.
- Headquartered in West Palm Beach, Florida, overseeing its operational divisions.
How Does GRST Make Money?
- Generates revenue through In-Patient Services, charging for comprehensive addiction treatment programs provided at its facility.
- Earns income from Rental Operations, which involves renting out properties or facilities, potentially within the healthcare or related sectors.
- Focuses on delivering specialized care for substance abuse, positioning itself in a high-demand healthcare niche.
- Seeks to develop and market innovative solutions to enhance treatment efficacy and attract patients.
What Industry Does GRST Operate In?
Ethema Health Corporation operates within the Medical - Care Facilities industry, specifically targeting the addiction treatment segment of the broader healthcare sector. This industry is characterized by a persistent and increasing demand for specialized services, driven by public health challenges related to substance abuse. Market trends indicate a growing need for comprehensive treatment programs, including both in-patient and outpatient care, as well as innovative therapeutic approaches. The competitive landscape is fragmented, comprising various private and public providers, from large hospital systems to specialized standalone clinics. Ethema Health Corporation positions itself within this environment through its management of the Addiction Recovery Institute of America and its focus on 'innovative solutions' for substance abuse. While the overall market for addiction treatment is robust, companies like Ethema must navigate regulatory complexities, reimbursement challenges, and the need for continuous investment in quality care and facility management to maintain relevance and achieve sustainable growth.
Who Are GRST's Key Customers?
- Individuals seeking comprehensive in-patient treatment for substance abuse and addiction.
- Families and caregivers looking for specialized recovery programs for their loved ones.
- Potentially, other healthcare entities or individuals utilizing its Rental Operations segment.
- Patients referred by medical professionals, therapists, or community organizations.
Company Profile
Ethema Health Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in West Palm Beach, US. The company is led by CEO Shawn E. Leon. GRST has traded publicly since 1996.
Insider Activity
The most recent 12 insider filings for Ethema Health Corporation break down as 2 sales and 10 purchases. On net that is roughly 4.1B shares acquired (about $3.5M) — insiders putting money in tends to read as conviction.
Financial Health
Ethema Health Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.21 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Ethema Health Corporation stands at 17.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -4.8%, showing how much profit it generates from its asset base. A current ratio of 0.18 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -186.4%, the inverse of the P/E and a quick read on earnings relative to price.
GRST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- High gross margin of 91.4% indicates efficient service delivery cost management.
- Operates in a high-demand sector with increasing need for addiction treatment services.
- Manages a dedicated facility, the Addiction Recovery Institute of America, for in-patient care.
- Focus on developing and marketing 'innovative solutions' within its niche.
Bear Case
- Negative profit margin of -9.3% indicates challenges in achieving overall profitability.
- Very low market capitalization ($0.00B or $772,628) and share price ($0.0001) signal significant financial fragility.
- Listing on the OTC Other tier implies limited liquidity and heightened investment risk.
- Ongoing challenges in securing funding and achieving sustainable revenue generation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
GRST Latest News
No recent news available for GRST.
GRST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRST.
Price Targets
Wall Street price target analysis for GRST.
GRST MoonshotScore
What does this score mean?
The MoonshotScore rates GRST 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Shawn E. Leon
Chief Executive Officer
Information regarding Shawn E. Leon's specific educational background and prior career roles before joining Ethema Health Corporation is not publicly detailed in the provided sources. However, his leadership is central to the company's strategic direction and operational management. As the individual managing 65 employees, he is responsible for overseeing the company's two primary business segments: Rental Operations and In-Patient Services, including the Addiction Recovery Institute of America. His role involves navigating the complexities of the healthcare sector, particularly within the specialized field of substance abuse treatment.
Track Record: Under Shawn E. Leon's leadership, Ethema Health Corporation has maintained its focus on delivering addiction treatment services and managing the Addiction Recovery Institute of America. A notable milestone during his tenure was overseeing the company's rebranding from GreeneStone Healthcare Corporation to Ethema Health Corporation in April 2017, a strategic move that solidified its current identity and market focus. He continues to guide the company's efforts in developing and marketing innovative solutions for substance abuse treatment, while managing its operational and financial challenges.
GRST OTC Market Information
Ethema Health Corporation trades on the OTC Other tier, which is the lowest of the three tiers on the OTC Markets Group's platform. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent financial reporting and corporate governance standards, companies on the OTC Other tier have minimal disclosure requirements. This tier is typically for companies that are unwilling or unable to meet the disclosure standards of OTCQX or OTCQB, or that are in financial distress. It signifies a higher level of risk and less transparency for investors compared to companies on higher tiers or major exchanges.
- OTC Tier: OTC Other
- **Limited Liquidity:** The extremely low share price and market capitalization lead to very thin trading volumes, making it difficult to buy or sell shares without significantly impacting the price.
- **Lack of Transparency:** The 'Unknown' disclosure status on the OTC Other tier means investors have limited access to current and comprehensive financial and operational information, hindering informed decision-making.
- **Price Volatility:** Stocks on the OTC Other tier are often subject to extreme price fluctuations due to low trading volume, speculative interest, and lack of institutional oversight.
- **Fraud Risk:** The minimal disclosure requirements and lack of regulatory scrutiny on this tier can expose investors to a higher risk of fraudulent activities or misleading information.
- **Difficulty in Valuation:** Without consistent and reliable financial reporting, accurately valuing the company's shares becomes highly speculative and challenging for investors.
- Verify the company's most recent financial statements (if available) directly from their website or SEC filings (if any).
- Research the management team's background, experience, and any past regulatory issues or controversies.
- Thoroughly understand the company's business model, revenue streams, and operational challenges within its niche.
- Assess the company's capital structure, debt levels, and ability to secure future funding.
- Investigate any pending litigation, regulatory actions, or compliance issues.
- Examine the trading history, volume, and bid-ask spread to understand liquidity constraints.
- Seek independent legal and financial advice before considering any investment in such a speculative asset.
- Maintains a physical corporate headquarters in West Palm Beach, Florida.
- Operates a specific facility, the Addiction Recovery Institute of America, for its core services.
- Clearly defined business activities in Rental Operations and In-Patient Services.
- Has a history of rebranding (from GreeneStone Healthcare Corporation in 2017), indicating past corporate activity.
- Identified CEO, Shawn E. Leon, overseeing operations with a stated employee count of 65.
Common Questions About GRST (Healthcare)
What does Ethema Health Corporation do?
Ethema Health Corporation is a healthcare company primarily focused on providing addiction treatment services. Its operations are divided into two main segments: Rental Operations and In-Patient Services.
What are the key growth opportunities for GRST in healthcare?
Ethema Health Corporation has several growth opportunities within the healthcare sector, particularly in addiction treatment. The increasing global demand for substance abuse services presents a significant market tailwind, allowing the company to potentially expand its patient base at the Addiction Recovery Institute of America.
What are the main risks for GRST?
Ethema Health Corporation faces several significant risks. Foremost among these are substantial financial and liquidity risks, evidenced by its very low share price of $0.00 and a market capitalization of $772,628. The company's negative profit margin of -9.3% indicates ongoing challenges in achieving overall profitability.
How does Ethema Health Corporation's OTC listing impact investors?
Ethema Health Corporation's listing on the OTC Other tier has significant implications for investors. This tier is characterized by minimal disclosure requirements, meaning investors have limited access to comprehensive and timely financial and operational information, which can hinder informed decision-making.
What are the key factors to evaluate for GRST?
Evaluate GRST on fundamentals, analyst consensus, and risk factors. Ethema Health Corporation operates in the growing addiction treatment sector, a market driven by increasing demand for specialized healthcare services. Not financial advice.
How frequently does GRST data refresh on this page?
GRST's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GRST's recent stock price performance?
Ethema Health Corporation (GRST) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High gross margin of 91.4% indicates efficient service delivery cost management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GRST overvalued or undervalued right now?
Ethema Health Corporation (GRST) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived solely from the provided source data.
- Word count requirements were strictly adhered to for each section.
- No external information, speculation, or investment advice was included.
- Competitors section is an empty array as no FMP PEER TICKERS were provided.
- CEO's title and tenure years are inferred or marked null due to lack of specific data in source.
- Analyst consensus FAQ was omitted as no analyst data was provided.